Discover your next big idea at PACK EXPO Las Vegas this September
Experience a breakthrough in packaging & processing and transform your business with solutions from 2,300 suppliers spanning all industries.
REGISTER NOW & SAVE

Free Pills from Government Boost Potassium Iodide Sales

Nukepills.com sees increased demand for emergency radiation drug.

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

The recent localized government handout of samples of potassium iodide has sky-rocketed sales for online merchant Nukepills.com. Recent retail orders of Iosat(TM) Potassium Iodide have increased by almost 400% and wholesale orders to vendors and medical facilities have surged as well for the authorized national distributor.

A limited supply of potassium iodide tablets was handed out to people residing within 10 miles of select nuclear plants.

However, radiation would not stop at the 10-mile mark, as radioactive iodine from the Chernobyl disaster blanketed the population for over 300 miles. "People from all over are realizing that they should stockpile an adequate supply of potassium iodide and are purchasing the individual retail packs of FDA-approved full-strength 130mg tablets from our website," said Troy Jones, president of Nukepills.com. "From parents to hospitals, it seems everyone is stocking up right now. We are getting volume orders from the Middle East and Asia as well."

Stockpiling of potassium iodide is recommended by health officials worldwide to prevent thyroid cancer of those exposed to radioactive iodine in the event of a nuclear reactor accident or detonation of a nuclear bomb.

FDA-approved in 1982, individually foil-sealed Iosat Potassium Iodide is available without a prescription and was granted a 7-year shelf life by the FDA. More information about FDA-approved potassium iodide can be found online.

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
Annual Outlook Report: Automation & Robotics
What's in store for CPGs in 2025 and beyond? <i>Packaging World</i> editors explore the survey responses from 118 brand owners, CPG, and FMCG <i>Packaging World</i> readers for its new Annual Outlook Report.
Download
Annual Outlook Report: Automation & Robotics